Immunosuppression PathPlex® Panel (CD3E, Cytokeratin, CD8 alpha, CD68, PD-L1, FOXP3)

CD3E, Cytokeratin, CD8 alpha, CD68, PD-L1, FOXP3

-

-

Unconjugated

-

1 year from date of receipt

Human

-

2 - 8°C

Recombinant Monoclonal

-

CD3-epsilon; TCRE; T-cell surface glycoprotein CD3 epsilon chain; T-cell surface antigen T3/Leu-4 epsilon chain; T-cell antigen receptor complex, epsilon subunit of T3; CD antigen CD3e; IMD18; CD3e molecule, epsilon (CD3-TCR complex); CD3e antigen, epsilon polypeptide (TiT3 complex); T3E; Leu2 T-lymphocyte antigen; T-lymphocyte differentiation antigen T8/Leu-2; T-cell surface glycoprotein CD8 alpha chain; T-cell antigen Leu2; T8 T-cell antigen; T cell co-receptor; OKT8 T-cell antigen; Leu2; CD8 antigen, alpha polypeptide (p32); CD8; CD antigen CD8a; p32; LAMP4; scavenger receptor class D, member 1; SCARD1; macrophage antigen CD68; GP110; CD68 antigen; CD antigen CD68; macrosialin; K10; Keratin-10; keratin, type I cytoskeletal 10; CK10; keratin 10, type I; KPP; Cytokeratin-10; CK-10; BIE; BCIE; cytokeratin 10; EHK; EBS4; NFJ; Keratin-14; keratin, type I cytoskeletal 14; K14; EBS3; Cytokeratin-14; cytokeratin 14; CK-14; CK14; keratin 14, type I; keratin, type I cytoskeletal 15; Cytokeratin-15; type I cytoskeletal 15; keratin-15, beta; keratin-15, basic; Keratin-15; CK15; K15; cytokeratin 15; CK-15; K1CO; keratin 15, type I; Keratin-16; PC1; KRT16A; keratin, type I cytoskeletal 16; keratin 16, type I; K1CP; focal non-epidermolytic palmoplantar keratoderma; FNEPPK; Cytokeratin-16; cytokeratin 16; CK-16; CK16; K16; NEPPK; K19; keratin, type I, 40-kd; keratin, type I cytoskeletal 19; K1CS; Keratin-19; Cytokeratin-19; cytokeratin 19; CK-19; CK19; 40-kDa keratin intermediate filament; keratin 19, type I; PDCD1L1; Programmed death ligand 1; programmed cell death 1 ligand 1; PD-L1; PDL1; PDCD1LG1; PDCD1 ligand 1; CD274 antigen; CD antigen CD274; B7-H1; B7H1; B7 homolog 1; B7-H; PIDX; scurfin; JM2; IPEX; immunodeficiency, polyendocrinopathy, enteropathy, X-linked; FOXP3delta7; forkhead box protein P3; XPID; DIETER; AIID; immune dysregulation, polyendocrinopathy, enteropathy, X-linked

Primary Antibodies

Primary Antibodies

12352203

7 Days

916, 925, 968, 3858, 3861, 3866, 3868, 3880, 29126, 50943

NP_000724.1

P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645, P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645, P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645, P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645, P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645, P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645, P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645, P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645, P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645, P19012, Q9BZS1, P01732, P34810, P02533, P08779, P08727, Q9NZQ7, P07766, P13645

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-